XML 84 R66.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHAREHOLDERS' EQUITY (Details Textual)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Sep. 27, 2021
₪ / shares
shares
Feb. 19, 2021
₪ / shares
shares
Feb. 19, 2021
₪ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
Dec. 31, 2021
USD ($)
$ / shares
Dec. 31, 2015
$ / shares
Dec. 31, 2023
₪ / shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
₪ / shares
shares
Dec. 22, 2022
USD ($)
Jul. 21, 2022
USD ($)
Jun. 02, 2022
₪ / shares
Jun. 02, 2022
USD ($)
Sep. 27, 2021
$ / shares
shares
Feb. 19, 2021
$ / shares
shares
Dec. 28, 2016
USD ($)
Shareholders Equity Textual Abstract                                  
Per share value of stock repurchase authorized | ₪ / shares               ₪ 0.25   ₪ 0.25              
Options granted (in shares)       0                          
Warrants to purchase ordinary shares       32,895                          
Warrants outstanding                 19,187,375                
Total number of warrants outstanding                 9,814,754                
Proceeds From Warrant Exercises | $       $ 13,800                          
Minimum [Member]                                  
Shareholders Equity Textual Abstract                                  
Exercise price per share | $ / shares                 $ 1.25                
Maximum [Member]                                  
Shareholders Equity Textual Abstract                                  
Exercise price per share | $ / shares                 $ 1.79                
Kreos Capital V [Member]                                  
Shareholders Equity Textual Abstract                                  
Warrants grant date             Dec. 31, 2015                    
Warrants Exercisable Descrition             currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of the Company with or into, or the sale or license of all or substantially all the assets or shares of the Company to, any other entity or person, other than a wholly owned subsidiary of the Company, excluding any transaction in which the Company’s shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction. None of these warrants had been exercised as of December 31, 2023.                    
Restricted Stock Units (RSUs) [Member]                                  
Shareholders Equity Textual Abstract                                  
Weighted average grant date fair value, restricted stock units (in USD per share) | $ / shares       $ 0.66 $ 1 $ 1.69                      
Employee Stock Option [Member]                                  
Shareholders Equity Textual Abstract                                  
Shares reserved for future issuance (in shares)                 1,018,945 2,934,679              
Unrecognized cost of shares | $                 $ 2,700                
Expected term of shares       2 years 10 months 24 days                          
Total fair value of shares vested | $       $ 1,268 $ 860 $ 802                      
Private Placement [Member]                                  
Shareholders Equity Textual Abstract                                  
Issuance expenses | $       3,679                          
Purchase agreement with certain institutional investors [Member]                                  
Shareholders Equity Textual Abstract                                  
Issuance of ordinary shares (in shares) 15,403,014                                
Per share value of stock repurchase authorized | ₪ / shares ₪ 0.25                                
Exercise price per share | $ / shares                             $ 2    
Number of warrants issued 8,006,759                           8,006,759    
Description of underwriting agreement The Pre-Funded Warrants have an exercise price of $0.001 per Ordinary Share and are immediately exercisable and can be exercised at any time after their original issuance until such pre-funded warrants are exercised in full. Each ordinary shares was sold at an offering price of $2.035 and each pre-funded warrant was sold at an offering price of $2.034 (equal to the purchase price per ordinary share minus the exercise price of the pre-funded warrant).                                
Purchase agreement with certain institutional investors [Member] | Additionally Warrants Issued [Member]                                  
Shareholders Equity Textual Abstract                                  
Issuance of ordinary shares (in shares) 610,504                                
Exercise price per share | $ / shares                             $ 2.5438    
Number of warrants issued 960,811                           960,811    
Purchase Agreement With Certain Institutional Accerdited Investors Member                                  
Shareholders Equity Textual Abstract                                  
Issuance of ordinary shares (in shares)   10,921,502                              
Shares issued price per share | $ / shares                               $ 3.6625  
Per share value of stock repurchase authorized | ₪ / shares   ₪ 0.25 ₪ 0.25                            
Exercise price per share | $ / shares                               $ 3.6  
Number of warrants issued   5,460,751 5,460,751                         5,460,751  
Warrants Exercisable Descrition     exercisable from February 19, 2021, until August 26, 2026                            
Purchase Agreement With Certain Institutional Accerdited Investors Member | Additionally Warrants Issued [Member]                                  
Shareholders Equity Textual Abstract                                  
Exercise price per share | $ / shares                               $ 4.578125  
Number of warrants issued   655,290 655,290                         655,290  
Warrants Exercisable Descrition     exercisable from February 19, 2021, until August 26, 2026                            
Certain institutional purchasers [Member] | Offering of ordinary shares in February 2020 [Member]                                  
Shareholders Equity Textual Abstract                                  
Number of warrants issued                   3,740,100              
Proceeds From Warrant Exercises | $         4,675,125                        
Certain institutional purchasers [Member] | Offering of ordinary shares in February 2020 Two [Member]                                  
Shareholders Equity Textual Abstract                                  
Number of warrants issued                   230,160              
Proceeds From Warrant Exercises | $         359,625                        
Certain institutional purchasers [Member] | Offering of ordinary shares in July 2020 [Member]                                  
Shareholders Equity Textual Abstract                                  
Number of warrants issued                   2,020,441              
Proceeds From Warrant Exercises | $         3,555,976                        
Certain institutional purchasers [Member] | Offering of ordinary shares in December 2020 [Member]                                  
Shareholders Equity Textual Abstract                                  
Number of warrants issued                   3,598,072              
Proceeds From Warrant Exercises | $         4,821,416                        
Certain institutional purchasers [Member] | December 2020 private placement [Member]                                  
Shareholders Equity Textual Abstract                                  
Number of warrants issued                   225,981              
Proceeds From Warrant Exercises | $         $ 405,003                        
Kreos Capital [Member]                                  
Shareholders Equity Textual Abstract                                  
Exercise price per share | $ / shares             $ 7.5                    
Drawdown amount under loan agreement | $                                 $ 8,000
Share Repurchase Program [Member]                                  
Shareholders Equity Textual Abstract                                  
Shares issued price per share | ₪ / shares                         ₪ 0.25        
Issuance expenses | $       $ 3,500                          
Number of ordinary shares repurchased, amount | $                     $ 5,800 $ 8,000   $ 8,000      
Outstanding ordinary shares repurchased, shares                 4,022,607